Curative Biotechnology, Inc.
CUBT
$0.01
$0.000.00%
OTC PK
| 09/30/2025 | 03/31/2025 | 09/30/2024 | 06/30/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -- | -481.60K | -- | -1.29M | -935.90K |
| Total Depreciation and Amortization | -- | 21.90K | -- | 2.00K | -4.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | 250.00K | -46.30K |
| Total Other Non-Cash Items | -- | 21.40K | -- | 77.40K | -19.60K |
| Change in Net Operating Assets | -- | 252.90K | -- | 647.40K | 426.40K |
| Cash from Operations | -- | -185.30K | -- | -310.70K | -579.80K |
| Capital Expenditure | -- | -- | -- | -- | -6.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -4.40K | 0.00 |
| Cash from Investing | -- | -- | -- | -4.40K | -6.80K |
| Total Debt Issued | -- | -- | -- | 200.00K | 70.00K |
| Total Debt Repaid | -- | -- | -- | -26.00K | 0.00 |
| Issuance of Common Stock | -- | 275.50K | -- | -- | 548.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 108.50K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -42.30K | -93.00K |
| Cash from Financing | -- | 384.00K | -- | 131.70K | 525.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 198.70K | -- | -183.40K | -61.60K |